Perfil
Branden S.
Moriarity holds the position of Chief Scientific Officer at B-MoGen Biotechnologies, Inc., founded in 2015.
Dr. Moriarity holds the position of Chief Innovation Officer at Luminary Therapeutics, Inc., founded in 2019.
Dr. Moriarity is the founder of B-MoGen Biotechnologies, Inc. Dr. Moriarity is the founder of Luminary Therapeutics, Inc. Dr. Moriarity is also the founder of Catamaran Bio, Inc...
Cargos activos de Branden S. Moriarity
| Empresas | Cargo | Inicio |
|---|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Fundador | 01/01/2015 |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Fundador | 01/01/2019 |
Antiguos cargos conocidos de Branden S. Moriarity.
| Empresas | Cargo | Fin |
|---|---|---|
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Commercial Services |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
- Bolsa de valores
- Insiders
- Branden S. Moriarity
















